Recital 1, Regulation (EU) 2026/2042

In forcesince 11 Sep 2026

On 30 September 2025, Evonik Operations GmbH submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 [Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj).] for a Union authorisation of the same biocidal product, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013, named ‘OXTERIL® 350 VHP’, of product-types 2 and 4, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-RG110491-49 in the Register for Biocidal Products. The application referred to the biocidal product family ‘Evonik’s Hydrogen Peroxide Product Family’ authorised by Commission Implementing Regulation (EU) 2023/2183 [Commission Implementing Regulation (EU) 2023/2183 of 18 October 2023 granting a Union authorisation for the biocidal product family Evonik’s Hydrogen Peroxide Product Family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council. (OJ L, 2023/2183, 19.10.2023, ELI: http://data.europa.eu/eli/reg_impl/2023/2183/oj).], with authorisation number EU-0028964-0000.